12:20 PM EST - Avicanna Inc. : Announced the launch of its medical cannabis program in Colombia, under compound pharmacy legislation “Formulaciones Magistrales”, in which Avicanna will provide its standardized, industry-leading cannabinoid formulary to patients and the medical community. Additionally, this program includes the education and training of the medical community and a comprehensive patient support program. Avicanna Inc.
shares T.AVCN are trading up $0.02 at $0.85.
